49 related articles for article (PubMed ID: 18793612)
21. PPARbeta/delta regulates paneth cell differentiation via controlling the hedgehog signaling pathway.
Varnat F; Heggeler BB; Grisel P; Boucard N; Corthésy-Theulaz I; Wahli W; Desvergne B
Gastroenterology; 2006 Aug; 131(2):538-53. PubMed ID: 16890607
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
[TBL] [Abstract][Full Text] [Related]
23. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
26. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
[TBL] [Abstract][Full Text] [Related]
27. Anti-apoptotic role of EGF in HaCaT keratinocytes via a PPARbeta-dependent mechanism.
Liang P; Jiang B; Huang X; Xiao W; Zhang P; Yang X; Long J; Xiao X; Huang X
Wound Repair Regen; 2008; 16(5):691-8. PubMed ID: 19128264
[TBL] [Abstract][Full Text] [Related]
28. Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression.
Tan NS; Michalik L; Di-Poï N; Ng CY; Mermod N; Roberts AB; Desvergne B; Wahli W
EMBO J; 2004 Oct; 23(21):4211-21. PubMed ID: 15470497
[TBL] [Abstract][Full Text] [Related]
29. Tributyltin is a potent inhibitor of piscine peroxisome proliferator-activated receptor α and β.
Colliar L; Sturm A; Leaver MJ
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Jan; 153(1):168-73. PubMed ID: 21035564
[TBL] [Abstract][Full Text] [Related]
30. [Not Available].
Jastrzębski MK; Wójcik P; Stępnicki P; Kaczor AA
Acta Pharm Sin B; 2024 Jan; 14(1):20-37. PubMed ID: 38239239
[TBL] [Abstract][Full Text] [Related]
31. Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity.
Sáez-Orellana F; Leroy T; Ribeiro F; Kreis A; Leroy K; Lalloyer F; Baugé E; Staels B; Duyckaerts C; Brion JP; Gailly P; Octave JN; Pierrot N
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34228639
[TBL] [Abstract][Full Text] [Related]
32. miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
Lee D; Tang W; Dorsey TH; Ambs S
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338277
[TBL] [Abstract][Full Text] [Related]
33. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.
Yu YE; Xing Z; Do C; Pao A; Lee EJ; Krinsky-McHale S; Silverman W; Schupf N; Tycko B
Prog Brain Res; 2020; 251():1-28. PubMed ID: 32057305
[TBL] [Abstract][Full Text] [Related]
34. Genetic dissection of the Down syndrome critical region.
Jiang X; Liu C; Yu T; Zhang L; Meng K; Xing Z; Belichenko PV; Kleschevnikov AM; Pao A; Peresie J; Wie S; Mobley WC; Yu YE
Hum Mol Genet; 2015 Nov; 24(22):6540-51. PubMed ID: 26374847
[TBL] [Abstract][Full Text] [Related]
35. Down syndrome critical region 2 protein inhibits the transcriptional activity of peroxisome proliferator-activated receptor beta in HEK293 cells.
Song HJ; Park J; Seo SR; Kim J; Paik SR; Chung KC
Biochem Biophys Res Commun; 2008 Nov; 376(3):478-82. PubMed ID: 18793612
[TBL] [Abstract][Full Text] [Related]
36. DSCR2, a Down syndrome critical region protein, is localized to the endoplasmic reticulum of mammalian cells.
Possik PA; Sommer CA; Issa Hori J; Machado-Santelli GM; Jamur MC; Henrique-Silva F
Eur J Histochem; 2004; 48(3):267-72. PubMed ID: 15590417
[TBL] [Abstract][Full Text] [Related]
37. Molecular and cellular characterization of the Down syndrome critical region protein 2.
Vesa J; Brown Y; Greenfield D; Korenberg JR
Biochem Biophys Res Commun; 2005 Mar; 328(1):235-42. PubMed ID: 15670775
[TBL] [Abstract][Full Text] [Related]
38. Down syndrome critical region gene 2: expression during mouse development and in human cell lines indicates a function related to cell proliferation.
Vidal-Taboada JM; Lu A; Pique M; Pons G; Gil J; Oliva R
Biochem Biophys Res Commun; 2000 May; 272(1):156-63. PubMed ID: 10872820
[TBL] [Abstract][Full Text] [Related]
39. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha.
Gray JP; Davis JW; Gopinathan L; Leas TL; Nugent CA; Vanden Heuvel JP
Toxicol Sci; 2006 Feb; 89(2):535-46. PubMed ID: 16280383
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
